Zepbound vs Wegovy trial and compounded GLP-1s
Podcast: Docs Who LiftPublished On: Mon Dec 09 2024
Description: Drs. Karl and Spencer discuss the topline results from Surmount 5 which put Zepbound (tirzepatide) against Wegovy (semaglutide) for weight loss. They also discuss some news around compounded GLP-1s.Learn:Weight loss and glycemic differences between tirzepatide and semaglutideWhat the FDA is thinking for compounded GLP-1sIf you're not on Dr. Spencer's virtual clinic waitlist, click here Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
The note was deleted
The note was saved
Your message was sent